Alfuzosin Versus Placebo in Acute Urinary Retention
NCT00453908
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
160
Enrollment
INDUSTRY
Sponsor class
Stopped
The study was early terminated due to slow and difficult recruitment
Conditions
Urinary Retention
Interventions
DRUG:
Alfuzosin
Sponsor
Sanofi